|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
WO2001072329A1
(en)
|
2000-03-29 |
2001-10-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing immunogenicity of antigens
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US7662396B2
(en)
*
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US8114414B2
(en)
*
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
WO2003102168A1
(en)
|
2002-05-29 |
2003-12-11 |
The Regents Of The University Of California |
Attenuated listeria spp. and methods for using the same
|
|
US8337861B2
(en)
|
2003-01-09 |
2012-12-25 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
US8906664B2
(en)
|
2004-08-13 |
2014-12-09 |
The Trustees Of The University Of Pennsylvania |
Methods for constructing antibiotic resistance free vaccines
|
|
US7855064B2
(en)
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
US7858097B2
(en)
*
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
WO2006045110A2
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Inc. |
High cell density process for growth of listeria
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
DK2977456T3
(en)
|
2006-08-15 |
2018-01-22 |
Univ Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof for the treatment of cancer
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
EP2147092A4
(en)
|
2007-04-16 |
2010-06-09 |
Univ Pennsylvania |
ANTIBIOTIC RESISTANCE-FREE LISTERIA TRIBES AND METHOD OF CONSTRUCTING AND USING THEREOF
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
CN102076843A
(zh)
*
|
2008-05-19 |
2011-05-25 |
艾杜罗生物科技公司 |
包含prfa*突变体李斯特菌的组合物及其使用方法
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20110129499A1
(en)
|
2008-05-19 |
2011-06-02 |
Paulo Maciag |
Dual delivery system for heterologous antigens
|
|
JP2011529077A
(ja)
*
|
2008-07-24 |
2011-12-01 |
アデュロ バイオテック |
Ｃ型肝炎の治療のための組成物および方法
|
|
PT2403935T
(pt)
|
2009-03-04 |
2017-09-22 |
Univ Pennsylvania |
Composições compreendendo fatores angiogénicos e metedos para a sua utilização
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
EP2498808A4
(en)
|
2009-11-11 |
2014-01-08 |
Advaxis |
COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
US20110305724A1
(en)
|
2010-04-19 |
2011-12-15 |
Yvonne Paterson |
Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
|
|
US9226958B2
(en)
|
2010-10-01 |
2016-01-05 |
University Of Georgia Research Foundation, Inc. |
Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
|
RS57630B1
(sr)
*
|
2010-11-17 |
2018-11-30 |
Aduro Biotech Inc |
Metode i sastavi za uzrokovanje imunog odgovora na egfrviii
|
|
AU2012229218B2
(en)
*
|
2011-03-11 |
2017-03-02 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
CN104411327A
(zh)
|
2012-03-12 |
2015-03-11 |
阿德瓦希斯公司 |
李斯特菌疫苗治疗以后的抑制细胞功能抑制
|
|
US10143734B2
(en)
|
2014-02-18 |
2018-12-04 |
Advaxis, Inc. |
Biomarker directed multi-target immunotherapy
|
|
KR20160122829A
(ko)
|
2014-02-25 |
2016-10-24 |
어드박시스, 인크. |
Ｈｅｒ2/ｎｅｕ 과발현 종양의 치료를 위한 조성물 및 방법
|
|
CA2941405A1
(en)
|
2014-03-05 |
2015-09-11 |
Advaxis, Inc. |
Methods and compositions for increasing a t-effector cell to regulatory t cell ratio
|
|
SG11201608820WA
(en)
|
2014-04-24 |
2016-11-29 |
Advaxis Inc |
Recombinant listeria vaccine strains and methods of producing the same
|
|
SG11201609135VA
(en)
|
2014-05-02 |
2016-11-29 |
Univ Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of her-2-positive cancers
|
|
WO2016011353A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
|
|
CA2955432A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Listeria-based immunogenic compositions for eliciting anti-tumor responses
|
|
CA2955612C
(en)
|
2014-07-18 |
2022-05-17 |
Advaxis, Inc. |
Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
|
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
|
SG10201903349YA
(en)
|
2014-10-14 |
2019-05-30 |
Univ Pennsylvania |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
MA41218A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Combinaison de vaccin à base de listeria comportant des anticorps anti-ox40 ou anti-gitr
|
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
|
WO2016126878A2
(en)
|
2015-02-03 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Listeria-based immunomodulation
|
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
|
WO2016183361A1
(en)
|
2015-05-13 |
2016-11-17 |
Advaxis, Inc. |
Immunogenic listeria-based compositions comprising truncated acta-antigen fusions and methods of use thereof
|
|
EP3302574A4
(en)
|
2015-05-26 |
2018-10-17 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
KR20180027501A
(ko)
|
2015-06-24 |
2018-03-14 |
어드박시스, 인크. |
맞춤형 전달 벡터-기반 면역 요법을 위한 제조 장치 및 공정
|
|
US20180305702A1
(en)
|
2015-09-15 |
2018-10-25 |
Advaxis, Inc. |
Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
|
|
US20180265879A1
(en)
|
2015-09-15 |
2018-09-20 |
Advaxis, Inc. |
Manufacturing method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
WO2017049218A2
(en)
|
2015-09-17 |
2017-03-23 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
EP3368675A1
(en)
|
2015-10-14 |
2018-09-05 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
WO2017085691A1
(en)
|
2015-11-20 |
2017-05-26 |
Advaxis, Inc. |
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
TW201726171A
(zh)
|
2015-12-16 |
2017-08-01 |
艾法西斯公司 |
以李斯特菌屬為主的免疫治療及其用法
|
|
AU2017211387A1
(en)
|
2016-01-27 |
2018-08-16 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
CA3029235A1
(en)
|
2016-07-05 |
2018-01-11 |
Advaxis, Inc. |
Listeria-based immunogenic compositions comprising wilms tumor protein antigens and methods of use thereof
|
|
US20200061167A1
(en)
|
2016-11-07 |
2020-02-27 |
Advaxis, Inc. |
Combination of listeria-based vaccine with anti-ctla-4 or anti-cd137 antibodies
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
JP7197481B2
(ja)
|
2016-11-30 |
2022-12-27 |
アドバクシス， インコーポレイテッド |
反復性がん突然変異を標的とする免疫原性組成物およびその使用の方法
|
|
AR110730A1
(es)
|
2017-01-05 |
2019-04-24 |
Advaxis Inc |
Vacunas de cepas recombinantes de listeria y método para usarlas en inmunoterapia de cáncer
|